Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia.

Daniel O Claassen Rajeev Ayyagari Viviana García-Horton Su Zhang Sam Leo

Published in: The mental health clinician (2023)

Identifying factors predictive of discontinuation and/or nonadherence to deutetrabenazine may facilitate the development of personalized support programs that seek to improve outcomes in patients with HD or TD.

Keyphrases

public health
glycemic control